Skip to content
Bomb Report – Lifestyle
Author:
BridgeBio Pharma, Inc.
BridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conference
March 6, 2026
BridgeBio Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial Updates
March 5, 2026
←
Previous Page
1
2
3
4